Federica Pisano

Pavia, 27100, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications

Tuning Tissue Ingrowth into Proangiogenic Hydrogels via Dual Modality Degradation.

Tuning Tissue Ingrowth into Proangiogenic Hydrogels via Dual Modality Degradation.

Journal: ACS biomaterials science & engineering
Published: October 14, 2019

Generation of the human induced pluripotent stem cell (hiPSC) line PSMi005-A from a patient carrying the KCNQ1-R190W mutation.

Generation of the human induced pluripotent stem cell (hiPSC) line PSMi005-A from a patient carrying the KCNQ1-R190W mutation.

Journal: Stem cell research
Published: March 04, 2019

Generation of two human induced pluripotent stem cell (hiPSC) lines from a long QT syndrome South African founder population.

Generation of two human induced pluripotent stem cell (hiPSC) lines from a long QT syndrome South African founder population.

Journal: Stem cell research
Published: February 25, 2019

Generation of the human induced pluripotent stem cell (hiPSC) line PSMi004-A from a carrier of the KCNQ1-R594Q mutation.

Generation of the human induced pluripotent stem cell (hiPSC) line PSMi004-A from a carrier of the KCNQ1-R594Q mutation.

Journal: Stem cell research
Published: February 21, 2019

Generation of the human induced pluripotent stem cell (hiPSC) line PSMi007-A from a Long QT Syndrome type 1 patient carrier of two common variants in the NOS1AP gene.

Generation of the human induced pluripotent stem cell (hiPSC) line PSMi007-A from a Long QT Syndrome type 1 patient carrier of two common variants in the NOS1AP gene.

Journal: Stem cell research
Published: January 28, 2019

Generation of the human induced pluripotent stem cell (hiPSC) line PSMi003-A from a patient affected by an autosomal recessive form of Long QT Syndrome type 1.

Generation of the human induced pluripotent stem cell (hiPSC) line PSMi003-A from a patient affected by an autosomal recessive form of Long QT Syndrome type 1.

Journal: Stem cell research
Published: February 16, 2018

Generation of the human induced pluripotent stem cell (hiPSC) line PSMi002-A from a patient affected by the Jervell and Lange-Nielsen syndrome and carrier of two compound heterozygous mutations on the KCNQ1 gene.

Generation of the human induced pluripotent stem cell (hiPSC) line PSMi002-A from a patient affected by the Jervell and Lange-Nielsen syndrome and carrier of two compound heterozygous mutations on the KCNQ1 gene.

Journal: Stem cell research
Published: February 16, 2018

Synthetic extracellular matrix mimic hydrogel improves efficacy of mesenchymal stromal cell therapy for ischemic cardiomyopathy.

Synthetic extracellular matrix mimic hydrogel improves efficacy of mesenchymal stromal cell therapy for ischemic cardiomyopathy.

Journal: Acta biomaterialia
Published: June 29, 2017

Optimized lentiviral transduction of human amniotic mesenchymal stromal cells.

Optimized lentiviral transduction of human amniotic mesenchymal stromal cells.

Journal: Pharmacological research
Published: June 21, 2017

The KCNH2-IVS9-28A/G mutation causes aberrant isoform expression and hERG trafficking defect in cardiomyocytes derived from patients affected by Long QT Syndrome type 2.

The KCNH2-IVS9-28A/G mutation causes aberrant isoform expression and hERG trafficking defect in cardiomyocytes derived from patients affected by Long QT Syndrome type 2.

Journal: International journal of cardiology
Published: January 16, 2017

microRNA and Cardiac Regeneration.

microRNA and Cardiac Regeneration.

Journal: Advances in experimental medicine and biology
Published: December 15, 2015

Conditioned medium from human amniotic mesenchymal stromal cells limits infarct size and enhances angiogenesis.

Conditioned medium from human amniotic mesenchymal stromal cells limits infarct size and enhances angiogenesis.

Journal: Stem cells translational medicine
Published: November 05, 2014
Showing 1-12 of 13

Last Updated: 09/26/2026